Persistence of HIV-1 variants harbouring the zidovudine resistance mutation at pol codon 215 in patients who respond to triple combination therapy

AIDS. 1998 May 7;12(7):824-5.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Anti-HIV Agents / pharmacology*
  • Anti-HIV Agents / therapeutic use
  • Codon
  • Drug Resistance, Microbial
  • Drug Therapy, Combination
  • Female
  • Genes, pol*
  • HIV Infections / drug therapy*
  • HIV Infections / immunology
  • HIV Infections / virology*
  • HIV Protease Inhibitors / therapeutic use*
  • HIV-1 / drug effects*
  • HIV-1 / genetics
  • HIV-1 / physiology
  • Humans
  • Indinavir / therapeutic use*
  • Lamivudine / therapeutic use*
  • Male
  • Mutation*
  • Prospective Studies
  • Reverse Transcriptase Inhibitors / pharmacology*
  • Reverse Transcriptase Inhibitors / therapeutic use
  • Stavudine / therapeutic use*
  • Treatment Outcome
  • Virus Latency
  • Zidovudine / pharmacology*

Substances

  • Anti-HIV Agents
  • Codon
  • HIV Protease Inhibitors
  • Reverse Transcriptase Inhibitors
  • Lamivudine
  • Zidovudine
  • Indinavir
  • Stavudine